Catalent, Inc. to Present at May 2020 Virtual Investor Conferences
May 08 2020 - 4:05PM
Business Wire
Catalent, Inc. (NYSE: CTLT), the leading global provider of
advanced delivery technologies, development, and manufacturing
solutions for drugs, biologics, cell and gene therapies, and
consumer health products, today announced that members of its
executive leadership team will present at two upcoming virtual
investor conferences. On May 12, 2020 at 11:40 a.m. ET, the Company
will present at the BofA Securities 2020 Health Care Conference. On
May 20, 2020 at 10:00 a.m. ET, the Company will present at the UBS
Global Healthcare Conference.
A live webcast of both presentations will be accessible through
the Company’s website at http://investor.catalent.com and will be
available for replay following the event.
About Catalent, Inc.
Catalent, Inc. (NYSE: CTLT) is the leading global provider of
advanced delivery technologies, development, and manufacturing
solutions for drugs, biologics, cell and gene therapies, and
consumer health products. With over 85 years serving the industry,
Catalent has proven expertise in bringing more customer products to
market faster, enhancing product performance and ensuring reliable
global clinical and commercial product supply. Catalent employs
more than 13,500 people, including approximately 2,400 scientists,
at more than 40 facilities across four continents and in fiscal
2019 generated over $2.5 billion in annual revenue. Catalent is
headquartered in Somerset, N.J. For more information, please visit
www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200508005383/en/
Investor Contact: Paul Surdez, Catalent, Inc. (732) 537-6325
investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
From Apr 2023 to Apr 2024